Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||0.00%||7.68||0.7%||$536.86m|
|GILD||Gilead Sciences, Inc.||0.00%||68.53||1.0%||$504.56m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.00%||516.62||2.7%||$432.65m|
|ALXN||Alexion Pharmaceuticals, Inc.||0.00%||173.49||2.0%||$412.31m|
|VRTX||Vertex Pharmaceuticals, Inc.||-1.00%||214.91||1.9%||$308.42m|
|CRSP||CRISPR Therapeutics AG||0.20%||106.85||0.6%||$171.75m|
|BNGO||Bionano Genomics, Inc.||-3.70%||5.20||0.0%||$156.74m|
Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic test. It operates through the Diagnostics and Other segments. The Diagnostics segment provides testing and collaborative development of testing that is designed to asses an individual's risk of developing a disease later in life. The Other segment offers products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients; and also includes corporate services such as finance, human resources, legal, and information technology. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.